Viracta Therapeutics, Inc.

VIRX · OTC
Analyze with AI
9/30/2024
6/30/2024
3/31/2024
12/31/2023
Operating Activities
Net Income-$11-$10-$9-$14
Dep. & Amort.-$1$0$0$0
Deferred Tax$0$0$0-$2
Stock-Based Comp.$1$1$2$2
Change in WC$2-$1-$0$2
Other Non-Cash$1-$0$2$1
Operating Cash Flow-$7-$10-$8-$10
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0-$0
Inv. Purchases-$3-$4-$6-$7
Inv. Sales/Matur.$12$15$20$17
Other Inv. Act.$0$0$14$0
Investing Cash Flow$8$12$14$9
Financing Activities
Debt Repay.-$2-$0-$7$0
Stock Issued-$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow-$2$0-$7$0
Forex Effect$0$0$0$0
Net Chg. in Cash-$1$2-$0-$1
Supplemental Information
Beg. Cash$14$12$12$13
End Cash$13$14$12$12
Free Cash Flow-$7-$10-$8-$10
Viracta Therapeutics, Inc. (VIRX) Financial Statements & Key Stats | AlphaPilot